ALGS vs CDNS · rev $3.6M vs P/E 82, rev $5.30B
Aligos Therapeutics Inc (ALGS) versus Cadence Design Systems Inc (CDNS) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
ALGS currently screens at market cap $44.1M. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Not investment advice. Open the ALGS and CDNS stock pages for the full models.
Not investment advice.